tanmay
panchabhai
md
fccp
case
present
man
present
ed
short
breath
weak
unintent
weight
loss
undergon
bilater
lung
transplant
cytomegaloviru
cmv
epsteinbarr
viru
idiopath
pulmonari
fibrosi
ipf
month
prior
posttranspl
cours
fairli
unremark
month
earlier
admit
breathless
weak
ct
chest
admiss
reveal
mild
intralobular
interlobular
septal
thicken
bronchoscopi
bal
transbronchi
biopsi
show
acut
cellular
reject
bal
fluid
posit
coronaviru
cortisol
level
undetect
diagnos
adren
insuffici
fludrocortison
initi
take
prednison
tacrolimu
everolimu
immunosuppress
valganciclovir
itraconazol
trimethoprimsulfamethoxazol
antimicrobi
prophylaxi
weight
loss
occur
span
one
month
patient
thin
weak
mildli
labor
breath
satur
lmin
supplement
oxygen
rest
vital
sign
normal
breath
sound
slightli
decreas
left
apex
base
without
adventiti
sound
palpabl
lymphadenopathi
appreci
laboratori
test
result
includ
cbc
metabol
panel
normal
cmv
epsteinbarr
viru
polymeras
chain
reaction
test
neg
ct
chest
show
bilater
small
layer
pleural
effus
well
new
leftsid
locul
pleural
effus
diffus
interlobular
intralobular
septal
thicken
promin
compar
prior
ct
imag
fig
also
note
new
mild
reticulonodular
opac
evid
enlarg
thorac
lymphadenopathi
lung
mass
observ
left
thoracentesi
reveal
ml
pale
yellow
exud
fluid
without
evid
lymphocytosi
cytolog
pleural
fluid
reveal
malign
cell
neg
result
videoassist
thoracoscop
surgeri
vat
lung
biopsi
perform
fig
diagnosi
lung
transplant
treatment
option
patient
endstag
lung
diseas
ipf
copd
cystic
fibrosi
pulmonari
arteri
hypertens
lung
cancer
lung
transplant
gener
rare
report
incid
individu
undergo
lung
transplant
diseas
copd
ipf
higher
chanc
develop
primari
lung
malign
smoke
histori
fibrot
lung
diseas
eg
ipf
also
increas
risk
fibrot
interstiti
process
recipi
singl
lung
transplant
smoke
histori
packyear
highest
risk
develop
lung
cancer
transplant
addit
donor
frequent
histori
smoke
may
increas
odd
lung
cancer
develop
lung
transplant
posttranspl
immunosuppress
includ
calcineurin
inhibitor
tacrolimu
cyclosporin
antimetabolit
drug
mycophenol
mofetil
azathioprin
prednison
also
increas
risk
develop
malign
transplant
drug
reduc
bodi
natur
antitumor
respons
primari
lung
malign
lung
transplant
gener
fall
one
follow
categori
cancer
recipi
explant
lung
incident
detect
upon
patholog
examin
lung
donorderiv
lung
cancer
malign
focu
donor
lung
undetect
preimplant
lung
cancer
nativ
lung
singlelung
transplant
recipi
new
primari
malign
lung
allograft
transplant
without
prior
evid
donor
recipi
malign
lung
transplant
recipi
develop
bronchogen
cancer
nonspecif
symptom
present
present
within
first
year
transplant
unless
cancer
amen
surgic
resect
respons
therapi
gener
extrem
poor
even
cancer
diagnos
earli
henc
new
lung
nodul
nativ
lung
patient
undergon
singl
lung
transplant
lung
allograft
evalu
rule
malign
lymphangit
carcinomatosi
pulmonari
tumor
embol
syndrom
foreign
materi
includ
tumor
cell
enter
venou
lymphat
system
lung
caus
local
lymphat
vessel
obstruct
fluid
accumul
turn
lead
thicken
alveolar
septa
bronchovascular
bundl
give
rise
typic
radiograph
pattern
diffus
intralobular
interlobular
septal
thicken
true
incid
lymphangit
carcinomatosi
unknown
less
solid
tumor
present
pattern
lymphangit
carcinomatosi
occur
adenocarcinoma
breast
kidney
lung
gastrointestin
tract
ie
liver
pancrea
stomach
lymphangit
carcinomatosi
endstag
manifest
diseas
carri
extrem
poor
prognosi
lung
transplant
recipi
presenc
interlobular
intralobular
septal
thicken
seen
varieti
differ
clinic
scenario
includ
acut
cellular
reject
antibodymedi
reject
pulmonari
edema
cmv
pneumon
posttranspl
lymphoprolif
disord
malign
pulmonari
extrapulmonari
sourc
rare
recurr
primari
lung
diseas
eg
sarcoidosi
tissu
diagnosi
key
clinic
present
associ
radiograph
featur
quit
divers
bronchoscopi
bal
transbronchi
lung
biopsi
like
first
diagnost
modal
obtain
tissu
mani
modal
differenti
diagnos
eg
acut
cellular
antibodymedi
reject
cmv
pneumon
posttranspl
lymphoprolif
disord
recurr
primari
diseas
high
diagnost
yield
although
specif
yield
transbronchi
biopsi
lymphangit
carcinomatosi
spars
studi
averag
diagnost
yield
thought
positron
emiss
tomographi
demonstr
high
specif
detect
lymphangit
carcinomatosi
especi
close
primari
tumor
vat
remain
procedur
choic
obtain
lung
biopsi
patient
toler
surgic
procedur
evid
point
diagnosi
patient
underw
bronchoscopi
transbronchi
lung
biopsi
bal
month
current
admiss
examin
show
evid
cellular
reject
bal
fluid
posit
coronaviru
prednison
burst
chestjournalorg
administ
given
patient
dramat
weight
loss
signific
worsen
interlobular
intralobular
septal
thicken
new
left
pleural
effus
malign
high
list
differenti
diagnos
cytolog
thoracentesi
nondiagnost
henc
vat
biopsi
perform
lower
lobe
left
lung
patholog
biopsi
analysi
show
cohes
cluster
malign
cell
lymphat
circul
fig
upon
immunohistochem
analysi
tumor
cell
found
posit
fig
fig
consist
diagnosi
pulmonari
adenocarcinoma
donor
case
younger
year
age
risk
factor
malign
recipi
howev
packyear
histori
smoke
nativ
lung
explant
origin
show
evid
cancer
review
conclus
therefor
adenocarcinoma
like
origin
recipi
lung
transplant
patient
famili
opt
comfort
care
measur
diagnosi
made
patient
transfer
hospic
servic
die
day
later
clinic
pearl
lung
cancer
lung
transplant
recipi
like
occur
nativ
lung
singlelung
transplant
recipi
incident
tumor
occasion
found
explant
lung
transmiss
malign
donor
exceedingli
rare
primari
lung
malign
allograft
may
atyp
present
andor
typic
present
eg
lung
mass
mediastin
adenopathi
differenti
diagnos
lung
transplant
recipi
includ
broad
rang
opportunist
infect
posttranspl
lymphoprolif
disord
malign
pulmonari
nonpulmonari
origin
high
index
suspicion
requir
given
rapid
progress
malign
immunosuppress
patient
associ
poor
clinic
outcom
lymphangit
carcinomatosi
rare
primari
present
lung
cancer
gener
seen
advanc
diseas
state
diagnosi
lymphangit
carcinomatosi
challeng
lung
transplant
recipi
differenti
diagnos
may
includ
acut
cellular
reject
antibodymedi
reject
pulmonari
edema
cmv
pneumon
posttranspl
lymphoprolif
disord
malign
pulmonari
extrapulmonari
sourc
rare
recurr
primari
lung
diseas
eg
sarcoidosi
tissu
biopsi
via
bronchoscopi
thoracoscopi
often
requir
establish
diagnosi
figur
highpow
magnif
lung
central
locat
bronchuspulmonari
arterylymphat
channel
complex
black
arrow
lymphat
channel
contain
cohes
cluster
larg
malign
cell
red
arrow
demonstr
increas
nuclear
size
increas
nuclearcytoplasm
ratio
nuclear
pleomorph
coars
clump
chromatin
hematoxylin
eosin
stain
b
lymphat
involv
adenocarcinoma
brown
nuclear
stain
blue
arrow
epithelium
bronchiol
stain
nuclei
darker
nuclei
carcinoma
green
arrow
immunostain
c
lymphat
involv
adenocarcinoma
brown
cytoplasm
stain
purpl
arrow
immunostain
pulmonari
critic
care
sleep
pearl
